Related references
Note: Only part of the references are listed.The survival benefit of postmastectomy radiotherapy for breast cancer patients with T1-2N1 disease according to molecular subtype
Jinli Wei et al.
BREAST (2020)
The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype
Francois Bertucci et al.
NPJ BREAST CANCER (2020)
Lymph node positivity in different early breast carcinoma phenotypes: a predictive model
Gilles Houvenaeghel et al.
BMC CANCER (2019)
Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised, controlled trial
Galina Velikova et al.
LANCET ONCOLOGY (2018)
Molecular subtyping of breast cancer improves identification of both high and low risk patients
Maria Rossing et al.
ACTA ONCOLOGICA (2018)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lymph node status in different molecular subtype of breast cancer: triple negative tumours are more likely lymph node negative
Ning Liu et al.
ONCOTARGET (2017)
Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer
Lars Jonson et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Cancers of unknown primary origin (CUP) are characterized by chromosomal instability (CIN) compared to metastasis of know origin
Jonas Vikesa et al.
BMC CANCER (2015)
Clinical implications of the intrinsic molecular subtypes of breast cancer
Aleix Prat et al.
BREAST (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Breast cancer subtypes can be determinant in the decision making process to avoid surgical axillary staging: A retrospective cohort study
Antonio Marrazzo et al.
INTERNATIONAL JOURNAL OF SURGERY (2015)
Reduced risk of axillary lymphatic spread in triple-negative breast cancer
Emil Villiam Holm-Rasmussen et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
A Predictive Tool to Estimate the Risk of Axillary Metastases in Breast Cancer Patients with Negative Axillary Ultrasound
T. J. Meretoja et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
A Simple Nomogram to Evaluate the Risk of Nonsentinel Node Metastases in Breast Cancer Patients with Minimal Sentinel Node Involvement
T. J. Meretoja et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Implementation of TMA and digitalization in routine diagnostics of breast pathology
Henrik Holm Rossing et al.
APMIS (2012)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
PAM50 assay and the three-gene model for identifying the major and clinically relevant molecular subtypes of breast cancer
A. Prat et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma
C. Ngo et al.
EJSO (2012)
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
Christina Curtis et al.
NATURE (2012)
A refined molecular taxonomy of breast cancer
M. Guedj et al.
ONCOGENE (2012)
The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
Fabien Reyal et al.
PLOS ONE (2011)
Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
David N. Krag et al.
LANCET ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A pathway-based classification of human breast cancer
Michael L. Gatza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive
Ben Van Calster et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Joel S. Parker et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Basal breast cancer molecular subtype predicts for lower incidence of axillary lymph node metastases in primary breast cancer
Simon J. Crabb et al.
CLINICAL BREAST CANCER (2008)
Predicting features of breast cancer with gene expression patterns
Xuesong Lu et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery - A prospective Swiss multicenter study on 659 patients
Igor Langer et al.
ANNALS OF SURGERY (2007)
Adjusting batch effects in microarray expression data using empirical Bayes methods
W. Evan Johnson et al.
BIOSTATISTICS (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
A. S. Doane et al.
ONCOGENE (2006)
Laser microdissection and microarray analysis of breast tumors reveal ER-α related genes and pathways
F Yang et al.
ONCOGENE (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution
G Viale et al.
CANCER (2005)
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
MH Dai et al.
NUCLEIC ACIDS RESEARCH (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer
U Veronesi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer
SF Abdessalam et al.
AMERICAN JOURNAL OF SURGERY (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
